| 000 | 01314 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518035149.0 | ||
| 264 | 0 | _c20200302 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1572-0241 | ||
| 024 | 7 |
_a10.14309/ajg.0000000000000215 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEpstein, Michael S | |
| 245 | 0 | 0 |
_aBeyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _c07 2019 |
||
| 300 |
_a1017-1019 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aConsumer Product Safety |
| 650 | 0 | 4 |
_aDrug Approval _xmethods |
| 650 | 0 | 4 | _aDrug Labeling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProgram Evaluation |
| 650 | 0 | 4 |
_aRisk Evaluation and Mitigation _xorganization & administration |
| 650 | 0 | 4 | _aSafety Management |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aUnited States Food and Drug Administration _xstandards |
| 700 | 1 | _aShah, Eric D | |
| 700 | 1 | _aDeepak, Parakkal | |
| 700 | 1 | _aKushnir, Vladimir M | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 114 _gno. 7 _gp. 1017-1019 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.14309/ajg.0000000000000215 _zAvailable from publisher's website |
| 999 |
_c29636169 _d29636169 |
||